tiprankstipranks
Trending News
More News >
Nuvation Bio (NUVB)
NYSE:NUVB
US Market
Advertisement

Nuvation Bio (NUVB) Stock Statistics & Valuation Metrics

Compare
548 Followers

Total Valuation

Nuvation Bio has a market cap or net worth of $1.01B. The enterprise value is $260.10M.
Market Cap$1.01B
Enterprise Value$260.10M

Share Statistics

Nuvation Bio has 342,272,740 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding342,272,740
Owned by Insiders26.99%
Owned by Institutions23.95%

Financial Efficiency

Nuvation Bio’s return on equity (ROE) is -1.22 and return on invested capital (ROIC) is -120.86%.
Return on Equity (ROE)-1.22
Return on Assets (ROA)-1.05
Return on Invested Capital (ROIC)-120.86%
Return on Capital Employed (ROCE)-1.23
Revenue Per Employee28.84K
Profits Per Employee-2.08M
Employee Count273
Asset Turnover0.01
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Nuvation Bio is ―. Nuvation Bio’s PEG ratio is ―.
PE Ratio
PS Ratio
PB Ratio
Price to Fair Value1.54
Price to FCF
Price to Operating Cash Flow-7.41
PEG Ratio

Income Statement

In the last 12 months, Nuvation Bio had revenue of 7.87M and earned -567.94M in profits. Earnings per share was -2.11.
Revenue7.87M
Gross Profit795.00K
Operating Income-592.63M
Pretax Income-567.94M
Net Income-567.94M
EBITDA-566.91M
Earnings Per Share (EPS)-2.11

Cash Flow

In the last 12 months, operating cash flow was -120.01M and capital expenditures -207.00K, giving a free cash flow of -120.22M billion.
Operating Cash Flow-120.01M
Free Cash Flow-120.22M
Free Cash Flow per Share-0.35

Dividends & Yields

Nuvation Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta2.13
52-Week Price Change22.58%
50-Day Moving Average2.45
200-Day Moving Average2.34
Relative Strength Index (RSI)77.12
Average Volume (3m)4.62M

Important Dates

Nuvation Bio upcoming earnings date is Nov 5, 2025, After Close (Confirmed).
Last Earnings DateAug 7, 2025
Next Earnings DateNov 5, 2025
Ex-Dividend Date

Financial Position

Nuvation Bio as a current ratio of 9.04, with Debt / Equity ratio of 54.54%
Current Ratio9.04
Quick Ratio9.04
Debt to Market Cap<0.01
Net Debt to EBITDA0.05
Interest Coverage Ratio-1.74K

Taxes

In the past 12 months, Nuvation Bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Nuvation Bio EV to EBITDA ratio is -1.21, with an EV/FCF ratio of -5.27.
EV to Sales87.40
EV to EBITDA-1.21
EV to Free Cash Flow-5.27
EV to Operating Cash Flow-5.28

Balance Sheet

Nuvation Bio has $607.72M in cash and marketable securities with $203.37M in debt, giving a net cash position of -$404.36M billion.
Cash & Marketable Securities$607.72M
Total Debt$203.37M
Net Cash-$404.36M
Net Cash Per Share-$1.18
Tangible Book Value Per Share$1.71

Margins

Gross margin is 27.54%, with operating margin of -7527.33%, and net profit margin of -7213.76%.
Gross Margin27.54%
Operating Margin-7527.33%
Pretax Margin-7213.76%
Net Profit Margin-7213.76%
EBITDA Margin-7200.75%
EBIT Margin-7209.42%

Analyst Forecast

The average price target for Nuvation Bio is $7.80, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$7.80
Price Target Upside128.07% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast900.35%
EPS Growth Forecast70.25%

Scores

Smart Score8
AI Score45
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis